ZJLD (06979) nominated Tang Xiangyang as an executive director.
Rare Wine Li Du (06979) announced that, based on the resolution passed by the board of directors on March 25, 2026, the board of directors has nominated Mr. Tang Xiangyang (Mr. Tang) as an executive director and Mr. Wen Jian (Mr. Wen, together with Mr. Tang are referred to as the proposed directors) as an independent non-executive director for the shareholders of the company to elect at the company's annual general meeting scheduled to be held on June 16, 2026 (Tuesday).
ZJLD (06979) announced that, according to the resolution passed by the board of directors on March 25, 2026, Mr. Tang Xiangyang (Mr. Tang) has been nominated as an executive director and Mr. Wen Jian (Mr. Wen, together with Mr. Tang referred to as the proposed directors) has been nominated as an independent non-executive director for election at the company's upcoming annual general meeting of shareholders scheduled for June 16, 2026 (Tuesday).
If Mr. Wen is elected as a director by the shareholders at the annual general meeting, he will also be appointed as a member of the company's audit committee, effective from the conclusion of the annual general meeting. Subsequently, Ms. Yan Jisheng will no longer serve as a member of the committee.
Related Articles

US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%

KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.

NEP INTERLONG (08329) released its performance for the year 2025, with a net loss attributable to shareholders of 40.739 million yuan.
US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%

KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.

NEP INTERLONG (08329) released its performance for the year 2025, with a net loss attributable to shareholders of 40.739 million yuan.






